相关实验视频
Updated: Jul 28, 2025

08:23
CIRCLE-Seq for Interrogation of Off-Target Gene Editing
Published on: November 1, 2024
715
针对PCSK9的新方法:小干扰型核糖核酸和基因组编辑
Reindert F Oostveen1, Amit V Khera2, Sekar Kathiresan2
1Department of Vascular Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, The Netherlands (R.F.O., E.S.G.S., J.J.P.K.).
Arteriosclerosis, thrombosis, and vascular biology
|June 1, 2023
概括
使用RNA干扰和基因组编辑,针对PCSK9 (proprotein convertase subtilisin/kexin type 9) 的新型疗法为患有非常高心血管风险的患者提供了有希望的长效解决方案,这些患者难以达到脂质目标.
科学领域:
- 心血管医学 心血管医学
- 遗传学 是一个遗传学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 降低低密度脂蛋白胆固醇 (LDL-C) 对心血管风险非常高的患者来说至关重要.
- 目前的降脂疗法往往无法达到指南推的LDL-C目标.
- 坚持和慢性护理的挑战限制了现有治疗方法的有效性.
研究的目的:
- 审查针对PCSK9 (proprotein convertase subtilisin/kexin type 9) 向脂质管理的演变情况.
- 探索新的治疗策略,包括mRNA,小干扰RNA和基因组编辑.
- 突出这些先进方法的潜力,以改善患者的治疗结果.
主要方法:
- 审查关于PCSK9抑制的历史和当前研究.
- 讨论基于mRNA和小干扰RNA (siRNA) 的疗法.
- 探索基因组编辑技术,包括CRISPR基因编辑.
主要成果:
- 抑制PCSK9代表了降低心血管风险的重大进展.
- 基于RNA的疗法可以持续有效地降低LDL-C.
- 基因组编辑,以VERVE-101为例,显示了持久PCSK9向的潜力.
结论:
- 针对PCSK9的新方法,如siRNA和基因组编辑,解决了心血管风险管理方面的未满足需求.
- 这些方法可以克服当前治疗方法的局限性,改善坚持和实现目标.
- 未来的研究和临床试验对于实现这些创新治疗的全部潜力至关重要.
相关概念视频
CRISPR/Cas9 Genome Editing
79
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
79
siRNA - Small Interfering RNAs
16.9K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.9K
CRISPR
52.5K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
52.5K
Experimental RNAi
6.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K
RNA Interference
26.1K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.1K

